Psychiatric Services
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Jindal, R. D.
* Articles by Thase, M. E.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Jindal, R. D.
* Articles by Thase, M. E.
Related Collections
* Bipolar Disorder
* Depression
* Mood Disorders (General)
* Psychotherapies (General)
* Antidepressants
Psychiatr Serv 54:1484-1490, November 2003
© 2003 American Psychiatric Association

Integration of Care: Integrating Psychotherapy and Pharmacotherapy to Improve Outcomes Among Patients With Mood Disorders

Ripu D. Jindal, M.D. and Michael E. Thase, M.D.

A number of studies have demonstrated comparable benefits of psychosocial interventions and pharmacologic treatments in subgroups of patients with mood disorders. The two treatment modalities are often combined in clinical practice. However, concerns about the costs of health care are paramount. For the optimum but judicious use of resources, it is valuable for mental health professionals to know the indications for and evidence pertaining to the efficacy of combined treatment. The authors demonstrate that a reexamination of existing research data in light of the recent advances in understanding of the design of clinical trials reveals a systematic underestimation of the benefits of combined treatment for certain subgroups of patients. Existing studies of combined treatments need to be reexamined in light of information about design sensitivity, ceiling effects, and nonspecific placebo effects. The authors summarize by arguing for a new generation of adequately powered investigations of efficacy, which they believe is necessary before the issue of cost-effectiveness can be properly addressed.




This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
E. Schramm, D. van Calker, P. Dykierek, K. Lieb, S. Kech, I. Zobel, R. Leonhart, and M. Berger
An Intensive Treatment Program of Interpersonal Psychotherapy Plus Pharmacotherapy for Depressed Inpatients: Acute and Long-Term Results
Am J Psychiatry, May 1, 2007; 164(5): 768 - 777.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
R. D. Jindal and M. E. Thase
Integrating Psychotherapy and Pharmacotherapy to Improve Outcomes Among Patients With Mood Disorders
Focus, January 1, 2005; 3(1): 114 - 121.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2003 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org